LYZA
- Product NDC
- 53002-1687
- 11-digit product format
- 530021687
- Labeler code
- 53002
- Product ID
- 53002-1687_92b408ff-5374-451f-94d2-5ee8b63718b2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- norethindrone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA200980
- Marketing category
- ANDA
- Marketing start
- 2013-06-24
- Marketing end
- 0000-00-00
- Substance
- NORETHINDRONE
- Active strength
- 0 mg/1
- Pharmacologic classes
- Progesterone Congeners [CS],Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53002-1687-1 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-f3a9-f424-e053-dadaa90a57ce | 5ce0eb18-6e34-4ec0-982b-2bddac311404 |
| 53002-1687-3 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-f3a9-f424-e053-dadaa90a57ce | 5ce0eb18-6e34-4ec0-982b-2bddac311404 |
| 53002-1687-6 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-f3a9-f424-e053-dadaa90a57ce | 5ce0eb18-6e34-4ec0-982b-2bddac311404 |
| 53002-1687-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f3a9-f424-e053-dadaa90a57ce | 5ce0eb18-6e34-4ec0-982b-2bddac311404 |
| 53002-1687-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f3a9-f424-e053-dadaa90a57ce | 5ce0eb18-6e34-4ec0-982b-2bddac311404 |
| 53002-1687-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f3a9-f424-e053-dadaa90a57ce | 5ce0eb18-6e34-4ec0-982b-2bddac311404 |